PAB.AXPAB.AXASX
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P14
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-42.89%
2024-59.18%
2023-6.93%
2022182.51%
2021109.21%
2020-18.86%
201928.97%
20183.31%
201721.41%
2016-77.70%